GSK3174998
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK3174998, covering 2021-05-18 to 2021-05-18. Get the full timeline:
Most recent: Clinical Trial Update: GSK3174998 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors (ENGAGE-1) [Phase 1]